These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16197548)

  • 1. Prediction of "hot spots" of aggregation in disease-linked polypeptides.
    Sánchez de Groot N; Pallarés I; Avilés FX; Vendrell J; Ventura S
    BMC Struct Biol; 2005 Sep; 5():18. PubMed ID: 16197548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases.
    Pawar AP; Dubay KF; Zurdo J; Chiti F; Vendruscolo M; Dobson CM
    J Mol Biol; 2005 Jul; 350(2):379-92. PubMed ID: 15925383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides.
    Conchillo-Solé O; de Groot NS; Avilés FX; Vendrell J; Daura X; Ventura S
    BMC Bioinformatics; 2007 Feb; 8():65. PubMed ID: 17324296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of aggregation-prone regions in structured proteins.
    Tartaglia GG; Pawar AP; Campioni S; Dobson CM; Chiti F; Vendruscolo M
    J Mol Biol; 2008 Jul; 380(2):425-36. PubMed ID: 18514226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressure-temperature folding landscape in proteins involved in neurodegenerative diseases and cancer.
    Cordeiro Y; Foguel D; Silva JL
    Biophys Chem; 2013 Dec; 183():9-18. PubMed ID: 23849959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging ideas on the molecular basis of protein and peptide aggregation.
    Thirumalai D; Klimov DK; Dima RI
    Curr Opin Struct Biol; 2003 Apr; 13(2):146-59. PubMed ID: 12727507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and aggregation mechanism of beta(2)-microglobulin (83-99) peptides studied by molecular dynamics simulations.
    Liang C; Derreumaux P; Wei G
    Biophys J; 2007 Nov; 93(10):3353-62. PubMed ID: 17693474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular dynamics approach to the structural characterization of amyloid aggregation.
    Cecchini M; Curcio R; Pappalardo M; Melki R; Caflisch A
    J Mol Biol; 2006 Apr; 357(4):1306-21. PubMed ID: 16483608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of the intrinsically unfolded protein beta-synuclein, a natural negative regulator of alpha-synuclein aggregation.
    Bertoncini CW; Rasia RM; Lamberto GR; Binolfi A; Zweckstetter M; Griesinger C; Fernandez CO
    J Mol Biol; 2007 Sep; 372(3):708-22. PubMed ID: 17681539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational characteristics of unstructured peptides: alpha-synuclein.
    Yoon J; Park J; Jang S; Lee K; Shin S
    J Biomol Struct Dyn; 2008 Apr; 25(5):505-15. PubMed ID: 18282005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins.
    Fernandez-Escamilla AM; Rousseau F; Schymkowitz J; Serrano L
    Nat Biotechnol; 2004 Oct; 22(10):1302-6. PubMed ID: 15361882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidogenic regions and interaction surfaces overlap in globular proteins related to conformational diseases.
    Castillo V; Ventura S
    PLoS Comput Biol; 2009 Aug; 5(8):e1000476. PubMed ID: 19696882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGGRESCAN: method, application, and perspectives for drug design.
    de Groot NS; Castillo V; Graña-Montes R; Ventura S
    Methods Mol Biol; 2012; 819():199-220. PubMed ID: 22183539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational prediction and redesign of aberrant protein oligomerization.
    Santos J; Iglesias V; Ventura S
    Prog Mol Biol Transl Sci; 2020; 169():43-83. PubMed ID: 31952691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurodegenerative conformational disease and its molecular bases].
    Li WW; Cai DF; Ren HM
    Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide aggregation in neurodegenerative disease.
    Murphy RM
    Annu Rev Biomed Eng; 2002; 4():155-74. PubMed ID: 12117755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration of alpha-synuclein aggregation by homologous peptides.
    Du HN; Li HT; Zhang F; Lin XJ; Shi JH; Shi YH; Ji LN; Hu J; Lin DH; Hu HY
    FEBS Lett; 2006 Jun; 580(15):3657-64. PubMed ID: 16764865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases.
    Breydo L; Uversky VN
    Metallomics; 2011 Nov; 3(11):1163-80. PubMed ID: 21869995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem-forming regions that are essential for the amyloidogenesis of prion proteins.
    Saiki M; Hidaka Y; Nara M; Morii H
    Biochemistry; 2012 Feb; 51(8):1566-76. PubMed ID: 22324778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.